RT Journal Article
SR Electronic
T1 717 A phase 1/2 study of AU-007, a monoclonal antibody (mAb) that binds to IL-2 and inhibits CD25 binding, in patients with advanced solid tumors: interim results from dose escalation
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A812
OP A812
DO 10.1136/jitc-2023-SITC2023.0717
VO 11
IS Suppl 1
A1 Frentzas, Sophia
A1 Ahern, Elizabeth
A1 Weickhardt, Andrew
A1 Haydon, Andrew
A1 Powderly, John
A1 Rasco, Drew
A1 McKean, Meredith
A1 Souza, Paul de
A1 Wyant, Timothy
A1 Tang, Jenny
A1 Richards, Lori
A1 Knickerbocker, Aron
A1 Amit, Inbar
A1 Ofran, Yanay
A1 Vasselli, James
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A812.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.